Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-16

FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, — Original Application (Eywa Pharma Inc)

View source ↗

Summary

FDA approved Eywa Pharma Inc for the original application of a generic brompheniramine maleate and pseudoephedrine hydrochloride combination product. This is a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brompheniramine maleate, pseudoephedrine hydrochloride (Brompheniramine maleate; Pseudoephedrine hydrochloride)

Snippet

ORIG AP for BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE,)